Exact Sciences
EXAS
#1179
Rank
NZ$32.27 B
Marketcap
NZ$169.93
Share price
0.04%
Change (1 day)
70.94%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Market capitalization of Exact Sciences (EXAS)

Market cap: NZ$32.27 Billion

As of January 2026 Exact Sciences has a market cap of NZ$32.27 Billion. This makes Exact Sciences the world's 1179th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exact Sciences from 2001 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$32.27 B-3.03%
2025NZ$33.28 B76.22%
2024NZ$18.88 B-10.73%
2023NZ$21.15 B52.69%
2022NZ$13.85 B-29.98%
2021NZ$19.78 B-28.35%
2020NZ$27.62 B36.26%
2019NZ$20.27 B74.92%
2018NZ$11.58 B30.84%
2017NZ$8.85 B323.62%
2016NZ$2.09 B60.38%
2015NZ$1.30 B-58%
2014NZ$3.10 B205.43%
2013NZ$1.01 B23.52%
2012NZ$0.82 B49.4%
2011NZ$0.55 B36.2%
2010NZ$0.40 B143.87%
2009NZ$0.16 B519.51%
2008NZ$26.76 M-76.54%
2007NZ$0.11 B6.06%
2006NZ$0.10 B25.84%
2005NZ$85.47 M-39.41%
2004NZ$0.14 B-53.06%
2003NZ$0.30 B-23.84%
2002NZ$0.39 B-14.77%
2001NZ$0.46 B

End of Day market cap according to different sources

On Jan 30th, 2026 the market cap of Exact Sciences was reported to be:

NZ$32.19 Billion
by Nasdaq info icon info icon
NZ$32.27 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
NZ$189.70 B 487.85%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
NZ$4.99 B-84.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
NZ$1.58 B-95.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
NZ$0.86 B-97.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
NZ$1.89 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA